Oncology Based Molecular Diagnostics Market 2027 by Product, Technology, Application and Geography | The Insight Partners

Oncology Based Molecular Diagnostics Market to 2027 - Global Analysis and Forecasts By Product (Instruments, Reagents and Kits, Others); Technology (PCR, Mass Spectrometry, In Situ Hybridization, Sequencing, Others); Application (Breast Cancer, Prostate Cancer, Lung Cancer, Blood Cancer, Lung Cancer, Others); and Geography

Report Code: TIPRE00006961 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Molecular diagnostics, at present has become a part of clinical diagnostics as the diagnostics is done on the basis of the gene of a person. Therefore, the use of molecular diagnostics has helped to diagnose cancer at early stage and to determine its treatment. For cancer diagnostics the type of cancer is determined from the blood sample or other body fluids. Also, the technological advancement in the field of molecular diagnostics has allowed to innovate the concept of precision or personalized medicine which is proving itself as boon for the cancer patients.

MARKET DYNAMICS

The oncology based molecular diagnostics market is likely to foster its growth during the forecast period owing to the factors such as rising use of molecular diagnostics as a clinical diagnostics, increasing genomic technology in medical sector and the growing incidences of the cancer across the world. The market is expected to have growth opportunities due to increasing development in the healthcare industries among the developing regions.

MARKET SCOPE

The "Global Oncology Based Molecular Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of oncology based molecular diagnostics market with detailed market segmentation by product, technology, application, and geography. The global oncology based molecular diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading oncology based molecular diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global oncology based molecular diagnostics market is segmented on the basis of product, technology, and application. Based on the product the market is segmented as instruments, reagents & kits and others. On the basis of technology the market is segmented as PCR, mass spectrometry, in situ hybridization, sequencing, and others. On the basis of application segment the market is classified as breast cancer, prostate cancer, lung cancer, blood cancer, lung cancer, and others.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oncology based molecular diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oncology based molecular diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting oncology based molecular diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the oncology based molecular diagnostics market in these regions.

MARKET PLAYERS


The reports cover key developments in the oncology based molecular diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from oncology based molecular diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for oncology based molecular diagnostics market in the global market. Below mentioned is the list of few companies engaged in the oncology based molecular diagnostics market.

The report also includes the profiles of key oncology based molecular diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  Abbott
  •  BD
  •  Agilent Technologies, Inc
  •  Danaher Corporation
  •  Qiagen N.V.
  •  F. Hoffmann-La Roche Ltd
  •  Siemens AG
  •  Sysmex Corporation
  •  Hologic, Inc.
  •  Cepheid
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oncology Based Molecular Diagnostics Market - By Product
1.3.2 Oncology Based Molecular Diagnostics Market - By Technology
1.3.3 Oncology Based Molecular Diagnostics Market - By Application
1.3.4 Oncology Based Molecular Diagnostics Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ONCOLOGY BASED MOLECULAR DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. ONCOLOGY BASED MOLECULAR DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. REAGENTS AND KITS
7.4.1. Overview
7.4.2. Reagents and Kits Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. PCR
8.3.1. Overview
8.3.2. PCR Market Forecast and Analysis
8.4. MASS SPECTROMETRY
8.4.1. Overview
8.4.2. Mass Spectrometry Market Forecast and Analysis
8.5. IN SITU HYBRIDIZATION
8.5.1. Overview
8.5.2. In Situ Hybridization Market Forecast and Analysis
8.6. SEQUENCING
8.6.1. Overview
8.6.2. Sequencing Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. BREAST CANCER
9.3.1. Overview
9.3.2. Breast Cancer Market Forecast and Analysis
9.4. PROSTATE CANCER
9.4.1. Overview
9.4.2. Prostate Cancer Market Forecast and Analysis
9.5. LUNG CANCER
9.5.1. Overview
9.5.2. Lung Cancer Market Forecast and Analysis
9.6. BLOOD CANCER
9.6.1. Overview
9.6.2. Blood Cancer Market Forecast and Analysis
9.7. LUNG CANCER
9.7.1. Overview
9.7.2. Lung Cancer Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Oncology Based Molecular Diagnostics Market Overview
10.1.2 North America Oncology Based Molecular Diagnostics Market Forecasts and Analysis
10.1.3 North America Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Product
10.1.4 North America Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Technology
10.1.5 North America Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Application
10.1.6 North America Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Oncology Based Molecular Diagnostics Market
10.1.6.1.1 United States Oncology Based Molecular Diagnostics Market by Product
10.1.6.1.2 United States Oncology Based Molecular Diagnostics Market by Technology
10.1.6.1.3 United States Oncology Based Molecular Diagnostics Market by Application
10.1.6.2 Canada Oncology Based Molecular Diagnostics Market
10.1.6.2.1 Canada Oncology Based Molecular Diagnostics Market by Product
10.1.6.2.2 Canada Oncology Based Molecular Diagnostics Market by Technology
10.1.6.2.3 Canada Oncology Based Molecular Diagnostics Market by Application
10.1.6.3 Mexico Oncology Based Molecular Diagnostics Market
10.1.6.3.1 Mexico Oncology Based Molecular Diagnostics Market by Product
10.1.6.3.2 Mexico Oncology Based Molecular Diagnostics Market by Technology
10.1.6.3.3 Mexico Oncology Based Molecular Diagnostics Market by Application
10.2. EUROPE
10.2.1 Europe Oncology Based Molecular Diagnostics Market Overview
10.2.2 Europe Oncology Based Molecular Diagnostics Market Forecasts and Analysis
10.2.3 Europe Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Product
10.2.4 Europe Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Technology
10.2.5 Europe Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Application
10.2.6 Europe Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Oncology Based Molecular Diagnostics Market
10.2.6.1.1 Germany Oncology Based Molecular Diagnostics Market by Product
10.2.6.1.2 Germany Oncology Based Molecular Diagnostics Market by Technology
10.2.6.1.3 Germany Oncology Based Molecular Diagnostics Market by Application
10.2.6.2 France Oncology Based Molecular Diagnostics Market
10.2.6.2.1 France Oncology Based Molecular Diagnostics Market by Product
10.2.6.2.2 France Oncology Based Molecular Diagnostics Market by Technology
10.2.6.2.3 France Oncology Based Molecular Diagnostics Market by Application
10.2.6.3 Italy Oncology Based Molecular Diagnostics Market
10.2.6.3.1 Italy Oncology Based Molecular Diagnostics Market by Product
10.2.6.3.2 Italy Oncology Based Molecular Diagnostics Market by Technology
10.2.6.3.3 Italy Oncology Based Molecular Diagnostics Market by Application
10.2.6.4 Spain Oncology Based Molecular Diagnostics Market
10.2.6.4.1 Spain Oncology Based Molecular Diagnostics Market by Product
10.2.6.4.2 Spain Oncology Based Molecular Diagnostics Market by Technology
10.2.6.4.3 Spain Oncology Based Molecular Diagnostics Market by Application
10.2.6.5 United Kingdom Oncology Based Molecular Diagnostics Market
10.2.6.5.1 United Kingdom Oncology Based Molecular Diagnostics Market by Product
10.2.6.5.2 United Kingdom Oncology Based Molecular Diagnostics Market by Technology
10.2.6.5.3 United Kingdom Oncology Based Molecular Diagnostics Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Oncology Based Molecular Diagnostics Market Overview
10.3.2 Asia-Pacific Oncology Based Molecular Diagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Technology
10.3.5 Asia-Pacific Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Oncology Based Molecular Diagnostics Market
10.3.6.1.1 Australia Oncology Based Molecular Diagnostics Market by Product
10.3.6.1.2 Australia Oncology Based Molecular Diagnostics Market by Technology
10.3.6.1.3 Australia Oncology Based Molecular Diagnostics Market by Application
10.3.6.2 China Oncology Based Molecular Diagnostics Market
10.3.6.2.1 China Oncology Based Molecular Diagnostics Market by Product
10.3.6.2.2 China Oncology Based Molecular Diagnostics Market by Technology
10.3.6.2.3 China Oncology Based Molecular Diagnostics Market by Application
10.3.6.3 India Oncology Based Molecular Diagnostics Market
10.3.6.3.1 India Oncology Based Molecular Diagnostics Market by Product
10.3.6.3.2 India Oncology Based Molecular Diagnostics Market by Technology
10.3.6.3.3 India Oncology Based Molecular Diagnostics Market by Application
10.3.6.4 Japan Oncology Based Molecular Diagnostics Market
10.3.6.4.1 Japan Oncology Based Molecular Diagnostics Market by Product
10.3.6.4.2 Japan Oncology Based Molecular Diagnostics Market by Technology
10.3.6.4.3 Japan Oncology Based Molecular Diagnostics Market by Application
10.3.6.5 South Korea Oncology Based Molecular Diagnostics Market
10.3.6.5.1 South Korea Oncology Based Molecular Diagnostics Market by Product
10.3.6.5.2 South Korea Oncology Based Molecular Diagnostics Market by Technology
10.3.6.5.3 South Korea Oncology Based Molecular Diagnostics Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Oncology Based Molecular Diagnostics Market Overview
10.4.2 Middle East and Africa Oncology Based Molecular Diagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Technology
10.4.5 Middle East and Africa Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Oncology Based Molecular Diagnostics Market
10.4.6.1.1 South Africa Oncology Based Molecular Diagnostics Market by Product
10.4.6.1.2 South Africa Oncology Based Molecular Diagnostics Market by Technology
10.4.6.1.3 South Africa Oncology Based Molecular Diagnostics Market by Application
10.4.6.2 Saudi Arabia Oncology Based Molecular Diagnostics Market
10.4.6.2.1 Saudi Arabia Oncology Based Molecular Diagnostics Market by Product
10.4.6.2.2 Saudi Arabia Oncology Based Molecular Diagnostics Market by Technology
10.4.6.2.3 Saudi Arabia Oncology Based Molecular Diagnostics Market by Application
10.4.6.3 U.A.E Oncology Based Molecular Diagnostics Market
10.4.6.3.1 U.A.E Oncology Based Molecular Diagnostics Market by Product
10.4.6.3.2 U.A.E Oncology Based Molecular Diagnostics Market by Technology
10.4.6.3.3 U.A.E Oncology Based Molecular Diagnostics Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Oncology Based Molecular Diagnostics Market Overview
10.5.2 South and Central America Oncology Based Molecular Diagnostics Market Forecasts and Analysis
10.5.3 South and Central America Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Product
10.5.4 South and Central America Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Technology
10.5.5 South and Central America Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Application
10.5.6 South and Central America Oncology Based Molecular Diagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Oncology Based Molecular Diagnostics Market
10.5.6.1.1 Brazil Oncology Based Molecular Diagnostics Market by Product
10.5.6.1.2 Brazil Oncology Based Molecular Diagnostics Market by Technology
10.5.6.1.3 Brazil Oncology Based Molecular Diagnostics Market by Application
10.5.6.2 Argentina Oncology Based Molecular Diagnostics Market
10.5.6.2.1 Argentina Oncology Based Molecular Diagnostics Market by Product
10.5.6.2.2 Argentina Oncology Based Molecular Diagnostics Market by Technology
10.5.6.2.3 Argentina Oncology Based Molecular Diagnostics Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ONCOLOGY BASED MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AGILENT TECHNOLOGIES, INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. DANAHER CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. QIAGEN N.V.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SIEMENS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SYSMEX CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HOLOGIC, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CEPHEID
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. BD
3. Agilent Technologies, Inc
4. Danaher Corporation
5. Qiagen N.V.
6. F. Hoffmann-La Roche Ltd
7. Siemens AG
8. Sysmex Corporation
9. Hologic, Inc.
10. Cepheid